20 Mar 2023 Stella’s FY22 revenue was up by 5.9% YoY to US$1,631m, mainly driven by a 0.4% YoY increase in shipment to 56.0m pairs and 5.2% YoY increase in ASP to US$28.5/pair (FY21: US$27.1/pair). GPM was up by 1.0ppt
13 Mar 2023 While the collapse in SVB will unlikely trigger another financial crisis, it could have a negative psychological impact on China markets. Many Chinese tech start-ups, especially those with dollar funding, have opened U.S. accounts at SVB. At
08 Mar 2023 CNE’s FY22 revenue was up by 22.0% YoY to Rmb2,679m, mainly due to a 20.9% YoY increase in power sales, which accounted for 78.9% of total revenue (FY21: 79.6%). Revenue from wind power rose by 13.9% YoY
02 Mar 2023 Pentamaster’s 4Q22 revenue increased 20.6% YoY from MYR122.4m in 4Q21 to MYR147.7m. Automated Test Equipment (ATE) segment revenue increased 9.5% YoY to MYR94.4m on strong demand from automotive business. Factory Automation Solutions (FAS) segment revenue surged 47.3%
01 Mar 2023 SIIC reported its FY22 result with an increase in revenue by 14.3% to Rmb8.3bn (2021: Rmb7.3bn), driven by i) 10.4% YoY increase in operation revenue to Rmb3.46bn in the light of the 1.5%/3.1% YoY growth in WWT/water
27 Feb 2023 Christopher Hui, secretary for HKSAR financial services and the treasury, said on Sunday that the HKEX will adopt new main board listing rules in March to allow listings by technology companies with no revenue or profit, and
14 Feb 2023 Vincent Medical (VM) issued a profit warning citing that its FY22 reported net profit is expected to turn into a loss of HK$15.0m to HK$20.0 as compared to a net profit of HK$60.7m in FY21. The loss,
13 Feb 2023 The Chinese medical device market is one of opportunities. It is both large and growing. China is among the ten largest medical devices markets worldwide and is regarded as one of the most promising markets. According to
10 Feb 2023 Naga’s FY22 revenue was up by 104% YoY to US$461m, mainly driven by 1) 207%/183%/87.8% YoY increase in mass market tables/mass market EGM/premium market given the fast recovery of international particularly ASEAN visitors to Cambodia and the
31 Jan 2023 Vinda announced FY22 results, with revenue increased by 8.1% YoY to HK$19.4bn, driven by resilient growth of 7.8%/ 9.6% YoY in the tissue/ personal care segment to HK$16.1bn/HK$3.3bn. Hit by the spreading of pandemic in China, 4Q22
